EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Therapeutic Effects of SP-8356, a Verbenone Derivative, with Multimodal Cytoprotective Mechanisms in an Ischemic Stroke Rat Model

Hwa Young Song, Sejong Jin iD, Sekwang Lee iD, Angela Melinda Anthony Jalin, Kyung-Hye Roh, Won-Ki Kim

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252312769 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Hwa Young Song und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Korea University College of Medicine, Seoul 02841, Republic of Korea. Hauptthemen laut MEDLINE: Disease Models, Animal, Ischemic Stroke, Infarction, Middle Cerebral Artery. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry and Energy, Korea Health Industry Development Institute, MD-PhD/Medical Scientist Training Program through the Korea Health Industry Development Institute (KHIDI).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An ischemic cerebral stroke results from the interruption of blood flow to the brain, triggering rapid and complex cascades of excitotoxicity, oxidative stress, and inflammation. Current reperfusion therapies, including intravenous thrombolysis and mechanical thrombectomy, cause further brain injury due to reperfusion-induced cytotoxicity. To date, novel cytoprotective therapies that could address these challenges have yet to be developed, likely due to the limitations of targeting a single pathologic mechanism. To address these unmet clinical needs, we investigated a synthetic verbenone derivative, SP-8356, as a potential multi-target cytoprotective agent for acute ischemic strokes. In transient middle cerebral artery occlusion (MCAO) rats, SP-8356 significantly reduced brain infarct and edema volumes while improving acute neurological deficits in a dose-dependent manner. Furthermore, SP-8356 improved long-term outcomes, particularly by reducing mortality. These potent cytoprotective effects of SP-8356 were achieved by suppressing the excessive production of free radicals and pro-inflammatory cytokines, reducing the infiltration of inflammatory cells, and mitigating increases in blood–brain barrier permeability. Additional research is needed to determine whether co-administration of SP-8356 can extend the therapeutic time window of reperfusion therapies by mitigating ischemia/reperfusion injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Disease Models, AnimalIschemic StrokeInfarction, Middle Cerebral ArteryAnimalsRatsMaleReperfusion InjuryRats, Sprague-DawleyBlood-Brain BarrierNeuroprotective AgentsOxidative StressCytoprotection

Stichwörter der Autor:innen

SP-8356blood–brain barrier (BBB)brain edemacytoprotectiveinflammationischemic strokemiddle cerebral artery occlusion (MCAO)oxidative stressverbenone

Substanzen

Neuroprotective Agents

Autor:innen und Institutionen

  • Department of Neuroscience, Korea University College of Medicine, Seoul 02841, Republic of Korea.
  • Central Research Institute, Shin Poong Pharmaceutical Company, Ltd., Ansan 15610, Republic of Korea.
  • Department of Anesthesiology and Pain Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan 15355, Republic of Korea.
  • Department of Physical Medicine and Rehabilitation, Korea University College of Medicine, Seoul 02841, Republic of Korea.

ORCID-Profile: Sejong Jin, Sekwang Lee

Förderung

  • Ministry of Trade, Industry and Energy
  • Korea Health Industry Development Institute
  • MD-PhD/Medical Scientist Training Program through the Korea Health Industry Development Institute (KHIDI)
  • Ministry of Health and Welfare, Republic of Korea
  • Technology Innovation Program
  • Ministry of Trade, Industry, and Energy, the Republic of Korea

Zitieren

APA

Song, H. Y., Jin, S., Lee, S., Jalin, A. M. A., Roh, K. H., & Kim, W. K. (2024). The Therapeutic Effects of SP-8356, a Verbenone Derivative, with Multimodal Cytoprotective Mechanisms in an Ischemic Stroke Rat Model. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252312769

Vancouver

Song HY, Jin S, Lee S, Jalin AMA, Roh KH, Kim WK. The Therapeutic Effects of SP-8356, a Verbenone Derivative, with Multimodal Cytoprotective Mechanisms in an Ischemic Stroke Rat Model. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252312769

BibTeX
@article{Song2024,
  author = {Song, Hwa Young and Jin, Sejong and Lee, Sekwang and Jalin, Angela Melinda Anthony and Roh, Kyung-Hye and Kim, Won-Ki},
  title = {The Therapeutic Effects of SP-8356, a Verbenone Derivative, with Multimodal Cytoprotective Mechanisms in an Ischemic Stroke Rat Model},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252312769}
}
Kostenlos starten →